Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
Claire F. Verschraegen, Silke Westphalen, Wei Hu, Evelyne Loyer, Andrzej Kudelka, Peter Völker, John Kavanagh, Melissa Steger, Klaus Dieter Schulz, Günter Emons
Dive into the research topics of 'Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.'. Together they form a unique fingerprint.